Medicine & Life Sciences
Breast Neoplasms
100%
Breast
48%
Tumor-Infiltrating Lymphocytes
42%
Neoplasms
39%
Carcinoma
31%
Estrogen Receptors
29%
Triple Negative Breast Neoplasms
23%
Immunohistochemistry
22%
Large-Core Needle Biopsy
21%
Neoplasm Metastasis
20%
Carcinoma, Intraductal, Noninfiltrating
18%
Ductal Carcinoma
18%
Progesterone Receptors
15%
Biomarkers
14%
Tumor Microenvironment
14%
Phyllodes Tumor
14%
Fibroepithelial Neoplasms
14%
durvalumab
13%
Poly(ADP-ribose) Polymerase Inhibitors
12%
Recurrence
12%
Fine Needle Biopsy
11%
olaparib
11%
Biopsy
9%
Uroplakin II
9%
Lymph Nodes
9%
Ligands
9%
Mammography
9%
cediranib
8%
Survival
8%
Neoadjuvant Therapy
8%
Trastuzumab
8%
Differential Diagnosis
8%
pertuzumab
8%
Nerve Sheath Neoplasms
7%
Fluorescence In Situ Hybridization
7%
Immunotherapy
7%
Therapeutics
7%
Adenoid Cystic Carcinoma
7%
Adenocarcinoma
7%
Fibroadenoma
7%
Inflammatory Breast Neoplasms
7%
Ovarian Neoplasms
7%
prexasertib
7%
Pathology
7%
Whole Exome Sequencing
7%
Pleomorphic Adenoma
6%
Neurilemmoma
6%